MedPath

Biological effect of diagnostic and therapeutic radiation on human blood cells

Not Applicable
Conditions
Health Condition 1: null- Patients of breast, cervix, head and neck and liver cancerundergoing diagnostic imaging (Mammography, CT scan, PET/CT, 4D CT) or therapeutic fractionated radiation
Registration Number
CTRI/2017/11/010566
Lead Sponsor
Tata Memorial Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Normal healthy volunteers exposed to background radiation: 50

2)Normal healthy volunteers exposed to diagnostic procedures:30

(healthy volunteers undergoing diagnostic mammogram, CT scans, PET/CT scans and x-rays as screening procedures)

3)Patients of breast, cervix, head and neck and liver cancer undergoing diagnostic imaging (Mammography, CT scan, PET/CT, 4D CT) or therapeutic fractionated radiation will be included in the study.

Exclusion Criteria

1)No family history of cancer

2)Not diagnosed with any radiosensitive syndrome like Ataxia talengectesia/fanconiâ??s anemia.

3)Patients with diagnostic radiation should not have received any previous chemotherapy, hormone therapy, targeted therapy or radiation therapy and should not have undergone any radiographic imaging in the preceding 6 weeks.

4)Patients with therapeutic radiation should not be planned for any chemotherapy, hormone therapy or targeted therapy during the period of blood sampling for this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DNA repair kinetics in terms of g H2AX expressionTimepoint: 3 years
Secondary Outcome Measures
NameTimeMethod
Changes in expression of genes associated with DNA repair responseTimepoint: 3 years;Changes in pro inflammatory and antiinflammatory cytokine profile.Timepoint: 3 years
© Copyright 2025. All Rights Reserved by MedPath